Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies

References

• SangerFCoulsonARA rapid method for determining sequences in DNA by primed synthesis with DNA polymeraseJ Mol Biol19759434414481100841
   PubMed Web of Science ®Google Scholar
• CurranMESplawskiITimothyKWVincentGMGreenEDKeatingMTA molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndromeCell19958057958037889573
   PubMed Web of Science ®Google Scholar
• WangQCurranMESplawskiIPositional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmiasNat Genet199612117238528244
   PubMed Web of Science ®Google Scholar
• WangQShenJSplawskiISCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndromeCell19958058058117889574
   PubMed Web of Science ®Google Scholar
• WatanabeHKoopmannTTLe ScouarnecSSodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humansJ Clin Invest200811862260226818464934
   PubMed Web of Science ®Google Scholar
• SabirINKilleenMJGraceAAHuangCLVentricular arrhythmogenesis: insights from murine modelsProg Biophys Mol Biol2008982–320821819041335
   PubMed Web of Science ®Google Scholar
• SchwartzPJPrioriSGSpazzoliniCGenotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmiasCirculation20011031899511136691
   PubMed Web of Science ®Google Scholar
• AckermanMJMohlerPJDefining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteinsCirc Res2010107445746520724725
   PubMed Web of Science ®Google Scholar
• MohlerPJSchottJJGramoliniAOAnkyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac deathNature2003421692363463912571597
   PubMed Web of Science ®Google Scholar
• VattaMAckermanMJYeBMutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndromeCirculation2006114202104211217060380
   PubMed Web of Science ®Google Scholar
• WoodmanSEParkDSCohenAWCaveolin-3 knockout mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascadeJ Biol Chem200227741389883899712138167
   PubMed Web of Science ®Google Scholar
• CronkLBYeBKakuTNovel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3Heart Rhythm20074216116617275750
   PubMed Web of Science ®Google Scholar
• ChenLMarquardtMLTesterDJSampsonKJAckermanMJKassRSMutation of an A-kinase-anchoring protein causes long-QT syndromeProc Natl Acad Sci USA200710452209902099518093912
   PubMed Web of Science ®Google Scholar
• AarnoudseAJNewton-ChehCde BakkerPICommon NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam StudyCirculation20071161101617576865
   PubMed Web of Science ®Google Scholar
• ArkingDEPfeuferAPostWA common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarizationNat Genet200638664465116648850
   PubMed Web of Science ®Google Scholar
• PlasterNMTawilRTristani-FirouziMMutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen’s syndromeCell2001105451151911371347
   PubMed Web of Science ®Google Scholar
• Tristani-FirouziMEtheridgeSPKir 2.1 channelopathies: the Andersen-Tawil syndromePflugers Arch2010460228929420306271
   PubMed Web of Science ®Google Scholar
• ZhangLBensonDWTristani-FirouziMElectrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotypeCirculation2005111212720272615911703
   PubMed Web of Science ®Google Scholar
• LopatinANNicholsCGInward rectifiers in the heart: an update on I(K1)J Mol Cell Cardiol200133462563811273717
   PubMed Web of Science ®Google Scholar
• Barajas-MartinezHHuDOntiverosGBiophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicryCirc Cardiovasc Genet201141515721148745
   PubMedGoogle Scholar
• TsuboiMAntzelevitchCCellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7)Heart Rhythm20063332833516500306
   PubMed Web of Science ®Google Scholar
• TesterDJAryaPWillMGenotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testingHeart Rhythm20063780080516818210
   PubMed Web of Science ®Google Scholar
• VegaALTesterDJAckermanMJMakielskiJCProtein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardiaCirc Arrhythm Electrophysiol20092554054719843922
   PubMed Web of Science ®Google Scholar
• LiuNPrioriSGDisruption of calcium homeostasis and arrhythmogenesis induced by mutations in the cardiac ryanodine receptor and calsequestrinCardiovasc Res200877229330118006488
   PubMed Web of Science ®Google Scholar
• SplawskiITimothyKWSharpeLMCa(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autismCell20041191193115454078
   PubMed Web of Science ®Google Scholar
• SplawskiITimothyKWDecherNSevere arrhythmia disorder caused by cardiac L-type calcium channel mutationsProc Natl Acad Sci USA20051022380898096 discussion8086808815863612
   PubMed Web of Science ®Google Scholar
• NavedoMFChengEPYuanCIncreased coupled gating of L-type Ca2+ channels during hypertension and Timothy syndromeCirc Res2010106474875620110531
   PubMed Web of Science ®Google Scholar
• ErxlebenCLiaoYGentileSCyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helicesProc Natl Acad Sci USA2006103103932393716537462
   PubMed Web of Science ®Google Scholar
• YarotskyyVGaoGPetersonBZElmslieKSThe Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivationJ Physiol2009587Pt 355156519074970
   PubMed Web of Science ®Google Scholar
• SicouriSTimothyKWZygmuntACCellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: effects of ranolazineHeart Rhythm20074563864717467634
   PubMed Web of Science ®Google Scholar
• SungRJWuYHLaiNHBeta-adrenergic modulation of arrhythmogenesis and identification of targeted sites of antiarrhythmic therapy in Timothy (LQT8) syndrome: a theoretical studyAm J Physiol Heart Circ Physiol20102981H33H4419855067
   PubMed Web of Science ®Google Scholar
• ChengEPYuanCNavedoMFRestoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring proteinCirc Res2011109325526121700933
   PubMed Web of Science ®Google Scholar
• CerroneMColombiBSantoroMBidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptorCirc Res20059610e77e8215890976
   PubMed Web of Science ®Google Scholar
• LiuNColombiBMemmiMArrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse modelCirc Res200699329229816825580
   PubMed Web of Science ®Google Scholar
• Fernandez-VelascoMRuedaARizziNIncreased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardiaCirc Res20091042201209 12p following 20919096022
   PubMed Web of Science ®Google Scholar
• SedejSHeinzelFRWaltherSNa+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutationCardiovasc Res2010871505920080988
   PubMed Web of Science ®Google Scholar
• KangGGiovannoneSFLiuNPurkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapyCirc Res2010107451251920595652
   PubMed Web of Science ®Google Scholar
• SinhaAMSchmidtMMarschangHRole of left ventricular scar and Purkinje-like potentials during mapping and ablation of ventricular fibrillation in dilated cardiomyopathyPacing Clin Electrophysiol200932328629019272055
   PubMed Web of Science ®Google Scholar
• TerentyevDKubalovaZValleGModulation of SR Ca release by luminal Ca and calsequestrin in cardiac myocytes: effects of CASQ2 mutations linked to sudden cardiac deathBiophys J20089542037204818469084
   PubMed Web of Science ®Google Scholar
• GyorkeIHesterNJonesLRGyorkeSThe role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calciumBiophys J20048642121212815041652
   PubMed Web of Science ®Google Scholar
• KnollmannBCChopraNHlaingTCasq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardiaJ Clin Invest200611692510252016932808
   PubMed Web of Science ®Google Scholar
• KirchheferUWehrmeisterDPostmaAVThe human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handlingJ Mol Cell Cardiol20104919510520302875
   PubMed Web of Science ®Google Scholar
• PrioriSGChenSRInherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesisCirc Res2011108787188321454795
   PubMed Web of Science ®Google Scholar
• SungRJLoCPHsiaoPYTienHCTargeting intracellular calcium cycling in catecholaminergic polymorphic ventricular tachycardia: a theoretical investigationAm J Physiol Heart Circ Physiol20113014H1625H163821742998
   PubMed Web of Science ®Google Scholar
• HilliardFASteeleDSLaverDFlecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark massJ Mol Cell Cardiol201048229330119835880
   PubMed Web of Science ®Google Scholar
• van der WerfCKannankerilPJSacherFFlecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardiaJ Am Coll Cardiol201157222244225421616285
   PubMed Web of Science ®Google Scholar
• WatanabeHChopraNLaverDFlecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humansNat Med200915438038319330009
   PubMed Web of Science ®Google Scholar
• KatritsisDRowlandEO’NunainSShakespeareCFPolonieckiJCammAJEffect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanismsEur Heart J19951612193019358682029
   PubMed Web of Science ®Google Scholar
• LiuNDenegriMRuanYFSodium channel blockers prevent triggered activity but not abnormal Ca2+ release in a knock-in mouse model with ryanodine receptor mutation R4496CCirculation201012221A13707
   Web of Science ®Google Scholar
• CaballeroRDolz-GaitonPGomezRFlecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectificationProc Natl Acad Sci USA201010735156311563620713726
   PubMed Web of Science ®Google Scholar
• LiuNRuanYDenegriMCalmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/−) mice with catecholaminergic polymorphic ventricular tachycardiaJ Mol Cell Cardiol201150121422220937285
   PubMed Web of Science ®Google Scholar
• HoogendijkMGDiagnostic dilemmas: overlapping features of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathyFront Physiol2012314422654761
   PubMed Web of Science ®Google Scholar
• NademaneeKVeerakulGNimmannitSArrhythmogenic marker for the sudden unexplained death syndrome in Thai menCirculation1997968259526009355899
   PubMed Web of Science ®Google Scholar
• ChenQKirschGEZhangDGenetic basis and molecular mechanism for idiopathic ventricular fibrillationNature199839266732932969521325
   PubMed Web of Science ®Google Scholar
• HuDBarajas-MartinezHBurashnikovEA mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotypeCirc-Cardiovasc Gene200923270278
   Google Scholar
• LondonBMichalecMMehdiHMutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmiasCirculation2007116202260226817967977
   PubMed Web of Science ®Google Scholar
• KattygnarathDMaugenreSNeyroudNMOG1: a new susceptibility gene for Brugada syndromeCirc Cardiovasc Genet20114326126821447824
   PubMedGoogle Scholar
• AntzelevitchCPollevickGDCordeiroJMLoss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac deathCirculation2007115444244917224476
   PubMed Web of Science ®Google Scholar
• BurashnikovEPfeifferRBarajas-MartinezHMutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac deathHeart Rhythm20107121872188220817017
   PubMed Web of Science ®Google Scholar
• DelpónECordeiroJMNúñezLFunctional effects of KCNE3 mutation and its role in the development of Brugada syndromeCirc Arrhythm Electrophysiol20081320921819122847
   PubMed Web of Science ®Google Scholar
• Barajas-MartínezHHuDFerrerTMolecular genetic and functional association of Brugada and early repolarization syndromes with S422L missense mutation in KCNJ8Heart Rhythm20129454855522056721
   PubMed Web of Science ®Google Scholar
• NademaneeKVeerakulGChandanamatthaPPrevention of ventricular fibrillation episodes in Brugada syndrome by catheter ablation over the anterior right ventricular outflow tract epicardiumCirculation2011123121270127921403098
   PubMed Web of Science ®Google Scholar
• SunsaneewitayakulBYaoYThamareeSZhangSEndocardial mapping and catheter ablation for ventricular fibrillation prevention in Brugada syndromeJ Cardiovasc Electrophysiol201223Suppl 1s10s1622988965
   PubMed Web of Science ®Google Scholar
• WatanabeHYangTStroudDMStriking in vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitroCirculation201112491001101121824921
   PubMed Web of Science ®Google Scholar
• HoekstraMMummeryCLWildeAABezzinaCRVerkerkAOInduced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmiasFront Physiol2012334623015789
   PubMed Web of Science ®Google Scholar
• YoshidaYYamanakaSRecent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regenerationCirculation20101221808720606130
   PubMed Web of Science ®Google Scholar
• TakahashiKTanabeKOhnukiMInduction of pluripotent stem cells from adult human fibroblasts by defined factorsCell2007131586187218035408
   PubMed Web of Science ®Google Scholar
• ZhangJWilsonGFSoerensAGFunctional cardiomyocytes derived from human induced pluripotent stem cellsCirc Res20091044e30e4119213953
   PubMed Web of Science ®Google Scholar
• MorettiABellinMWellingAPatient-specific induced pluripotent stem-cell models for long-QT syndromeN Engl J Med2010363151397140920660394
   PubMed Web of Science ®Google Scholar
• MossAJKassRSLong QT syndrome: from channels to cardiac arrhythmiasJ Clin Invest200511582018202416075042
   PubMed Web of Science ®Google Scholar
• ItzhakiIMaizelsLHuberIModelling the long QT syndrome with induced pluripotent stem cellsNature2011471733722522921240260
   PubMed Web of Science ®Google Scholar
• MatsaERajamohanDDickEDrug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutationEur Heart J201132895296221367833
   PubMed Web of Science ®Google Scholar
• LahtiALKujalaVJChapmanHModel for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell cultureDis Model Mech20125222023022052944
   PubMed Web of Science ®Google Scholar
• MalanDFriedrichsSFleischmannBKSassePCardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitroCirc Res2011109884184721799153
   PubMed Web of Science ®Google Scholar
• DavisRPCasiniSvan den BergCWCardiomyocytes derived from pluripotent stem cells recapitulate electrophysiological characteristics of an overlap syndrome of cardiac sodium channel diseaseCirculation2012125253079309122647976
   PubMed Web of Science ®Google Scholar
• RemmeCAVerkerkAONuyensDOverlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insDCirculation2006114242584259417145985
   PubMed Web of Science ®Google Scholar
• YazawaMHsuehBJiaXUsing induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndromeNature2011471733723023421307850
   PubMed Web of Science ®Google Scholar
• FatimaAXuGShaoKIn vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cellsCell Physiol Biochem201128457959222178870
   PubMedGoogle Scholar
• JungCBMorettiAMederos y SchnitzlerMDantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardiaEMBO Mol Med20124318019122174035
   PubMed Web of Science ®Google Scholar
• AckermanMJGenetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?Curr Opin Cardiol200520317518115861004
   PubMed Web of Science ®Google Scholar
• GoldenbergIBradleyJMossABeta-blocker efficacy in high-risk patients with the congenital long-QT syndrome types 1 and 2: implications for patient managementJ Cardiovasc Electrophysiol201021889390120233272
   PubMed Web of Science ®Google Scholar
• LiuJFJonsCMossAJRisk factors for recurrent syncope and subsequent fatal or near-fatal events in children and adolescents with long QT syndromeJ Am Coll Cardiol201157894195021329841
   PubMed Web of Science ®Google Scholar
• TesterDJWillMLHaglundCMAckermanMJCompendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testingHeart Rhythm20052550751715840476
   PubMed Web of Science ®Google Scholar
• MossAJZarebaWKaufmanESIncreased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channelCirculation2002105779479911854117
   PubMed Web of Science ®Google Scholar
• MigdalovichDMossAJLopesCMMutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndromeHeart Rhythm20118101537154321440677
   PubMed Web of Science ®Google Scholar
• KimJALopesCMMossAJTrigger-specific risk factors and response to therapy in long QT syndrome type 2Heart Rhythm20107121797180520850565
   PubMed Web of Science ®Google Scholar
• ShimizuWHorieMOhnoSMutation site-specific differences in arrhythmic risk and sensitivity to sympathetic stimulation in the LQT1 form of congenital long QT syndrome: multicenter study in JapanJ Am Coll Cardiol200444111712515234419
   PubMed Web of Science ®Google Scholar
• CrottiLSpazzoliniCSchwartzPJThe common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratificationCirculation2007116212366237517984373
   PubMed Web of Science ®Google Scholar
• CrottiLMontiMCInsoliaRNOS1AP is a genetic modifier of the long-QT syndromeCirculation2009120171657166319822806
   PubMed Web of Science ®Google Scholar
• GiudicessiJRAckermanMJDeterminants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromesTransl Res Epub9172012
   Web of Science ®Google Scholar
• KoboriASaraiNShimizuWAdditional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndromeJ Cardiovasc Electrophysiol200415219019915028050
   PubMed Web of Science ®Google Scholar
• PrioriSGSchwartzPJNapolitanoCRisk stratification in the long-QT syndromeN Engl J Med2003348191866187412736279
   PubMed Web of Science ®Google Scholar
• SplawskiITristani-FirouziMLehmannMHSanguinettiMCKeatingMTMutations in the hminK gene cause long QT syndrome and suppress IKs functionNat Genet19971733383409354802
   PubMed Web of Science ®Google Scholar
• AbbottGWSestiFSplawskiIMiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmiaCell199997217518710219239
   PubMed Web of Science ®Google Scholar
• AiTFujiwaraYTsujiKNovel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmiaCirculation2002105222592259412045162
   PubMed Web of Science ®Google Scholar
• YeBTesterDJVattaMMakielskiJCAckermanMJAB1-1: Molecular and functional characterization of novel cav3-encoded caveolin-3 mutations in congenital long QT syndromeHeart Rhythm200635S116688893
   PubMedGoogle Scholar
• DomingoAMKakuTTesterDJAB16-6: sodium channel β4 subunit mutation causes congenital long QT syndromeHeart Rhythm200635S34
   Google Scholar
• Medeiros-DomingoAKakuTTesterDJSCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndromeCirculation2007116213414217592081
   PubMed Web of Science ®Google Scholar
• UedaKValdiviaCMedeiros-DomingoASyntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complexProc Natl Acad Sci USA2008105279355936018591664
   PubMed Web of Science ®Google Scholar
• WuGAiTKimJJAlpha-1-syntrophin mutation and the long-QT syndrome: a disease of sodium channel disruptionCirc Arrhythm Electrophysiol20081319320119684871
   PubMed Web of Science ®Google Scholar
• YangYLiangBLiuJIdentification of a Kir3.4 mutation in congenital long QT syndromeAm J Hum Genet201086687288020560207
   PubMed Web of Science ®Google Scholar
• KapplingerJWildeAAntzelevitchCA worldwide compendium of putative Brugada syndrome associated mutations in the SCN5A encoded cardiac sodium channelHeart Rhythm20096S392
   Google Scholar
• Schulze-BahrEEckardtLBreithardtGSodium channel gene (SCN5A) mutations in 44 index patients with Brugada syndrome: different incidences in familial and sporadic diseaseHum Mutat200321665165214961552
   PubMedGoogle Scholar
• Medeiros-DomingoATanBHCrottiLGain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromesHeart Rhythm20107101466147120558321
   PubMed Web of Science ®Google Scholar
• GiudicessiJRYeDTesterDJTransient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndromeHeart Rhythm2011871024103221349352
   PubMed Web of Science ®Google Scholar
• LaitinenPJBrownKMPiippoKMutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardiaCirculation2001103448549011157710
   PubMed Web of Science ®Google Scholar
• PrioriSGNapolitanoCTisoNMutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardiaCirculation2001103219620011208676
   PubMed Web of Science ®Google Scholar
• LahatHPrasEOlenderTA missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from IsraelAm J Hum Genet20016961378138411704930
   PubMed Web of Science ®Google Scholar
• PostmaAVDenjoyIHoorntjeTMAbsence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardiaCirc Res2002918e21e2612386154
   PubMed Web of Science ®Google Scholar
• PostmaAVBhuiyanZAShkolnikovaMInvolvement of the Kir2 gene family in catecholaminergic polymorphic ventricular tachycardia; analysis for mutations and identification of numerous pseudogenesEur Heart J20042566
   Web of Science ®Google Scholar
• MohlerPJSplawskiINapolitanoCA cardiac arrhythmia syndrome caused by loss of ankyrin-B functionProc Natl Acad Sci USA2004101249137914215178757
   PubMed Web of Science ®Google Scholar
• BrugadaRHongKDumaineRSudden death associated with short-QT syndrome linked to mutations in HERGCirculation20041091303514676148
   PubMed Web of Science ®Google Scholar
• BellocqCvan GinnekenACBezzinaCRMutation in the KCNQ1 gene leading to the short QT-interval syndromeCirculation2004109202394239715159330
   PubMed Web of Science ®Google Scholar
• PrioriSGPanditSVRivoltaIA novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 geneCirc Res200596780080715761194
   PubMed Web of Science ®Google Scholar
• TemplinCGhadriJRRougierJSIdentification of a novel loss-of-function calcium channel gene mutation in short QT syndrome (SQTS6)Eur Heart J20113291077108821383000
   PubMed Web of Science ®Google Scholar